A TECHNO-ECONOMIC NEWS MAGAZINE FOR MEDICAL PLASTICS AND PHARMACEUTICAL INDUSTRY
Our 11th Year of Publication

Page 3 of 8

Seminar Report

Medical Plastics : Materials, Applications And Processing

For Medical Devices And Pharmaceuticals Industries

Genotoxicity

  • These tests apply mammalian or non-mammalian cell culture techniques to determine 

  • gene mutations 

  • changes in chromosomal structure and number 

  • other DNA or gene toxicities

          caused by the device, material or their extracts

Implantation

  • Assesses the local pathological effects on the living tissue, at both the gross level and microscopic levels 

  • Sample of the material or the device is surgically implanted in an appropriate site (muscle, dentin or bone) based on the intended application 

  • Note : For a material, these tests are equivalent to sub chronic toxicity tests, if systemic effects are also investigated

Haemocompatibility

  • Evaluates the effects on blood or blood components by blood contacting devices or materials 

  • Specific haemocompatibility tests may have to be designed to simulate the 

  • Geometry 

  • contact conditions 

  • flow dynamics  

          of the final application 

  • Haemolysis tests determine the degree of blood cell lysis and release of hemoglobin caused by device / material samples

Chronic Toxicity 

  • Estimates the effects of either single or multiple exposures, during the period of at least 10% of the life span of the animal model, to medical devices, materials or their extracts in suitable animal model 

Carcinogenicity

  • These tests determine the tumorigenic potential of medical devices, materials or their extracts 

  • The test duration shall cover a period over the major portion of the life span of the animal model 

  • Can be carried out along with chronic toxicity studies 

  • Note : Required to be conducted only if there are suggestive data from other sources 

Reproductive & Developmental Toxicity

  • Studies the potential effects on 

  • reproductive function 

  • embryonic development (teratogenicity) 

  • prenatal and early post natal development 

  • Note : Need to be conducted only if the device has potential impact on the reproductive potential of the subject

Biodegradation

  • Where the potential for resorption / degradation exists, these tests determine the 

  • process of degradation 

  • biotransformation 

  • elimination of degradation products 

  • Note : ISO 10993 is not very specific on the norms for selection of biodegradation studies; only the method is described

Basis for Selection of Tests 

  • Categorization based on the nature of contact with human body

  • Non contact devices 

  • Surface contacting devices 

  • External communicating devices 

  • Implant devices

  • Categorization based on the duration of contact

  • Limited exposure devices (< 24 hours) 

  • Prolonged exposure devices (multiple or long term exposure up to 30 days) 

  • Permanent contact devices (contact exceeds 30 days)

Non contact devices

  • Packaging materials 

  • Medical instruments that does not come in contact with either the patient or the operator (Eg. Electrical components in a medical instrument) 

  • No specific biological qualification is required except ensuring that these materials does not introduce leachants into the contacting products that could become harmful.

Surface contacting devices

  • Skin : Devices that contact intact skin surfaces only  

  • Electrodes, fixation tapes, compression bandages and various monitors 

  • Mucosal membranes : Devices that contact intact mucosal membranes only 

  • Endo tracheal tubes, contact lenses, bronchoscopes, intra uterine devices 

  • Breached or compromised surfaces : Devices that contact breached or otherwise compromised body surfaces 

  • Wound dressings, occlusive patches for ulcers, burns etc.

Back | Back To Top| Next